Zobrazeno 1 - 10
of 268
pro vyhledávání: '"factor V inhibitor"'
Autor:
Brandon Travis Wiggins, Daniel Ramirez, Daniel Taylor, William Reichardt, Alyssa Kipke, Mark Minaudo
Publikováno v:
Hematology Reports, Vol 14, Iss 4, Pp 290-293 (2022)
Liver cirrhosis is commonly associated with coagulopathies, typically demonstrated by elevated prothrombin time, international normalized ratio, and partial thromboplastin time. In the setting of bleeding related to coagulopathies, oftentimes physici
Externí odkaz:
https://doaj.org/article/7217fad3416a4034873518591d05efa7
Autor:
Andrea Ceglédi, János Dolgos, Mónika Fekete, László Gopcsa, Andrea Várkonyi, Beáta Vilimi, Gábor Mikala, Imre Bodó
Publikováno v:
Pathology and Oncology Research, Vol 29 (2023)
Introduction: Acquired factor V inhibitor (AFVI) is a rare autoimmune bleeding disorder. The treatment of AFVI is challenging, and patients often require both bleeding control and inhibitor eradication.Methods: We conducted a retrospective analysis o
Externí odkaz:
https://doaj.org/article/f3fb4d10ceb74643a485e64375a24cf0
Autor:
Riccardo Bruna, Riccardo Moia, Alessandra Valpreda, Enrico Dosio, Roberta Rolla, Augusto Federici, Umberto Dianzani, Gianluca Gaidano, Andrea Patriarca
Publikováno v:
Clinical Case Reports, Vol 9, Iss 1, Pp 98-101 (2021)
Abstract This case report highlights the challenges in controlling bleeding and correcting coagulation tests through the use of bypassing agents in patients with FV inhibitors.
Externí odkaz:
https://doaj.org/article/7bd23d4cab9c4b1ba10d3d34d35396b3
Autor:
Hiromichi Bamba, Minami Nakagawa, Masaki Iwasa, Kousuke Hiroe, Katsuyuki Kito, Rie Osaki, Akira Andoh, Masahiro Kawahara, Kazuki Kakuda, Osamu Inatomi, Yoshihiro Yokota, Shigeki Sakai
Publikováno v:
Internal Medicine. 60:2663-2666
Acquired coagulation factor V (FV) inhibitors are rare disorders in which antibodies against FV develop under various conditions. We herein report the case of a 71-year-old woman with FV inhibitor during radiochemotherapy for pancreatic cancer. Multi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07d0c32a4b1d148e103410a4c30390c3
https://doi.org/10.2169/internalmedicine.7453-21
https://doi.org/10.2169/internalmedicine.7453-21
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Alessandra Valpreda, Enrico Dosio, Augusto B. Federici, Andrea Patriarca, Umberto Dianzani, Gianluca Gaidano, Riccardo Bruna, Riccardo Moia, Roberta Rolla
Publikováno v:
Clinical Case Reports, Vol 9, Iss 1, Pp 98-101 (2021)
Clinical Case Reports
Clinical Case Reports
This case report highlights the challenges in controlling bleeding and correcting coagulation tests through the use of bypassing agents in patients with FV inhibitors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5bae5e41280df0ab397428c7dc4ffbf
https://doaj.org/article/7bd23d4cab9c4b1ba10d3d34d35396b3
https://doaj.org/article/7bd23d4cab9c4b1ba10d3d34d35396b3
Publikováno v:
Clinical Case Reports, Vol 9, Iss 2, Pp 623-628 (2021)
Clinical Case Reports
Clinical Case Reports
Acquired factor V inhibitor represents a rare condition, described only in case reports. The use of activated bypassing agents in bleeding control could be of aid and improve the survival in symptomatic patients with acquired factor V inhibitor.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::944306acd3d92027dde3e0e072d1f095
https://doaj.org/article/1b871170de314a25b0ad4dd556be9dfc
https://doaj.org/article/1b871170de314a25b0ad4dd556be9dfc
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nadine Ajzenberg, Elodie Rabut, Nicolas Schleinitz, Annabelle Dupont, Thomas Papo, Dorothée Faille, Tiphaine Goulenok, Emmanuelle de Raucourt, Chloé James, Karim Sacre, Corinne Frere, Claire Vasco, Lucia Rugeri
Publikováno v:
British Journal of Haematology. 192:892-899
Acquired factor V inhibitor (AFVI) is an extremely rare disorder that may cause severe bleeding. To identify factors associated with bleeding risk in AFVI patients, a national, multicentre, retrospective study was made including all AFVI patients fol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbd64f07a0df145c43c452b8bfb73528
https://doi.org/10.1111/bjh.17308
https://doi.org/10.1111/bjh.17308
Autor:
Wijdene El Borgi, Ikbel Ghachem, Fatma Ben Lakhal, Emna Gouider, Iheb Ghiriani, Amel Chelbi, Sarra Fekih Salem
Publikováno v:
Annales de Biologie Clinique. 78:206-209
Factor V deficiency is a rare hemostatic disorder. It may present with a diverse spectrum of symptoms due to a variety of mechanisms including development of autoantibodies associated with a number of conditions. We report a first case of factor V de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6227e8d81e43b9abcaa0adb3faf5c96a
https://doi.org/10.1684/abc.2020.1540
https://doi.org/10.1684/abc.2020.1540